当前位置: 首页 >> 检索结果
3001. [Study, using the Allium test, of the antimitotic properties of rufochromomycin].3002. [Metoclopramide in the treatment of radiation sickness and digestive disorders caused by anticancer chemotherapy. (Apropos of 50 cases)].3003. [Demonstration of an hemato-protective effect of phytohemagglutinin administered in continuous treatment during anti-cancer polychemotherapy].3005. [Research on the cytotoxicity of organic combinations of phosphoric acid derivatives. 3. Action of trisubstituted (dialkylaryl and dialkylaralkyl) derivatives of O-phosphoric acid on the human cancer cell cultivated in vitro (HeLa test)].3006. [Study on the role of phytohemagglutinin in man as a hematologic protector during massive anticancer chemotherapy].3009. [Rapid method for quantitative evaluation of cytotoxic activity in tissue culture by electronic cell counting].3014. [Action of N-monomethyl-3,5-dimethylbenzheparide-amide and o-p'-dichlorodiphenyldichloroethane, alone or combined, on cancerization of the rat liver by p-dimethylaminoazobenzene].3015. [On the tumor growth-inhibiting action of colchicine].3016. [On the evaluation of the persistence of the antimitotic activity of alkylating agents in solution].3018. [Bone marrow grafts after total irradiation of leukemic mice followed by administration of an antimitotic agent to reduce the incidence of a secondary syndrome and to enhance the antileukemic effect].3019. [Research, by means of phase contrast microcinematography, on the antimitotic action of an active principle of Anemone pulsatilla L.: protoanemonine].3020. [Grafts of bone marrow after total irradiation of leukemic mice followed by the administration of an antimitotic product]. |